The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables

2014 ◽  
Vol 45 (6) ◽  
pp. 679-687 ◽  
Author(s):  
Gulay Turan ◽  
Ceyda Sancakli Usta ◽  
Akin Usta ◽  
Mehmet Kanter ◽  
Lema Tavli ◽  
...  
Cancer ◽  
1992 ◽  
Vol 70 (12) ◽  
pp. 2857-2860 ◽  
Author(s):  
Jeffrey D. Seidman ◽  
Dennis M. Frisman ◽  
Henry J. Norris

1991 ◽  
Vol 10 (3) ◽  
pp. 252-259 ◽  
Author(s):  
Hironobu Sasano ◽  
Yuko Saito ◽  
Hiroshi Nagura ◽  
Ryuichi Kudo ◽  
Magaly Rojas ◽  
...  

1999 ◽  
Vol 434 (2) ◽  
pp. 117-120 ◽  
Author(s):  
C. J. Haas ◽  
Joachim Diebold ◽  
Astrid Hirschmann ◽  
Helmut Rohrbach ◽  
Udo Löhrs

2013 ◽  
Vol 32 (4) ◽  
pp. 1-8 ◽  
Author(s):  
Nasta Tanić ◽  
Vedrana Milinković ◽  
Tatjana Dramićanin ◽  
Milica Nedeljković ◽  
Tijana Stanković ◽  
...  

Summary Background: Breast cancer is the most common form of cancer in women. It arises from multiple genetic changes in oncogenes and tumor suppressor genes. Among so far studied oncogenes relatively few, including epdermal growth factor receptor (EGFR), cyclinD1 (CCND1)and cmyc, have been found to play an important role in progression of this type of human malignancy. The aim of this study was to examine the prognostic potential of CCND1, c-myc and EGFR amplification and their possible cooperation in breast carcinogenesis. Methods: Copy number analyses of CCND1 and c-myc genes were done by TaqMan based quantitative real time PCR. Am pli fication status of EGFR was determined by differential PCR. Results: Amplification of CCND1, c-myc and EGFR onco- gene has been found in 20.4%, 26.5% and 26.5% of breast cancer cases, respectively. Analysis showed that amplification of CCND1 oncogene was significantly associated with the stage II of disease while amplification of EGFR gene was sig- nificantly associated with overexpression of HER-2/neu. Tu- mour stage and expression of HER-2/neu appeared to be significant predictors of patient's outcome. Stage I patients lived significantly longer then stage III patients (p=0.04) while patients with FiER-2/neu overexpression had worse prognoses and lived significantly shorter (p=0.001). Finally, survival of patients who underwent hormone therapy only was significantly longer (p=0.001) then survival of the rest of patients. Conclusions: Amplification of CCND1 or EGFR oncogene is associated with the progression of breast cancer and bad prognosis. No co-ordination in amplification of CCND1, c- myc and EGFR oncogenes were established in this cohort of breast cancer patients.


2016 ◽  
Vol 47 (2) ◽  
pp. 145-152 ◽  
Author(s):  
Mehmet Kanter ◽  
Gulay Turan ◽  
Ceyda Usta ◽  
Akin Usta ◽  
H. Hasan Esen ◽  
...  

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e11015-e11015
Author(s):  
Valmarie Ramos-Lamboy ◽  
Fernando Cabanillas ◽  
Miguel M. Echenique ◽  
Victor Carlo ◽  
Viviana Negron ◽  
...  

e11015 Background: Oncotype Dx (OD) is a commercially available gene-profiling test that has been shown to be effective in predicting risk of recurrence after therapy with CMF or Tamoxifen. The aim of our study is to develop a method that uses easily available clinical data to predict cases with favorable OD category (ODC). Methods: We identified 145 ER+/Her-2 neg cases that had information on histologic grade (HG), PR status and Oncotype Dx Category (ODC). Of these, 75 also had information on Ki-67. We evaluated HG, ER status, PR status, Nottingham score and tumor size for their correlation with ODC using multiple regression analysis. Results: The median tumor size was 12.0 mm (0.6-45). 33.7% were HG 1, 54% were grade 2, and 12% were grade 3. 88% were invasive ductal carcinomas, 9% were invasive lobular carcinomas, 3% were other types. The median OD score was 15 (0-57) with 86 (59%) ODC=1, 53 (37%) ODC=2 and 6 (4%) ODC=3; median Ki-67 was 11% (1-50). In a multivariate analysis excluding Ki-67, the only factors that were significantly correlated with ODC were PR status and HG (p= 0.004). PR status had the strongest overall association with ODC (P=0.008). Defining PR> 60% with HG=1 as a positive result we calculated the positive predictive value (PPV) or the capacity to predict cases with ODC=1, as 85% and negative predictive value (NPV) as 46%. None of the cases with PR> 60% and HG=1 had an ODC=3 (high risk). A patient with a favorable ODC=1 was considered as a positive case for purpose of calculating PPV, NPV, sensitivity and specificity. Sensitivity to detect positive cases was 26% and specificity was 93%. We explored a 2nd model that included Ki-67 and found that only PR >60% and Ki-67 >11% significantly correlated with ODC (p=0.004). PR status again had the strongest overall association with ODC (P=0.007) followed by Ki-67 (P=0.019). HG was not significant in the 2nd multivariate model because of its strong correlation with Ki-67. PPV for this 2nd model was 79% and NPV=50%. Conclusions: 1-Pts who have PR>60% with HG=1 are highly likely to have a favorable ODC=1, however the ODC of pts with either PR<60% or HG>1 is not predictable with either of our two models. 2- The use of Ki-67 doesn’t add much to the capacity of the model to predict ODC. 3- PR is the strongest predictive factor in the model.


1987 ◽  
Vol 73 (6) ◽  
pp. 539-545 ◽  
Author(s):  
Jerzy Rabczynski ◽  
Julia K. Bar ◽  
Anna Noworolska ◽  
Mieczyslaw Cislo ◽  
Roman Richer ◽  
...  

The cells of tumor fluid from patients with malignant and benign serous ovarian neoplasms were fractionated using Ficoll-Uropoline density gradient centrifugation. Density distribution and morphologic characteristics of cell fractions were analyzed. It was found that serous ovarian adenocarcinomas contained three to four types of morphologically malignant cells focused in low density layers. Borderline ovarian neoplasms showed the presence of one subpopulation of cells with some features of malignancy and cells with some atypical but non-malignant features. The fluids of serous cysts contained mainly normal epithelial cells representing different stages of morphological maturity and were focused in denser layers. The results allowed us to catalogue ovarian tumor cell subpopulations present in each density fraction of individual patients and confirmed that ovarian tumors could be diagnosed by morphologic identification of cells from tumor fluids.


2004 ◽  
Vol 171 (4S) ◽  
pp. 114-114
Author(s):  
Akira Yokomizo ◽  
Hirofumi Koga ◽  
Koji Okumura ◽  
Tatsuo Konomoto ◽  
Taiji Tsukamoto ◽  
...  

2008 ◽  
Author(s):  
Ming-Chuan Hsu ◽  
Chee-Yin Chai ◽  
Ming-Feng Hou ◽  
Hui-Chiu Chang ◽  
Wan-Tzu Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document